Caudal dexmedetomedine versus magnesium sulphate added to bupivacaine for caudal block in pediatric infra-umbilical orthopedic surgeries :
Phase 4
- Conditions
- PaediatricsOrthopaedics
- Registration Number
- PACTR201807487797587
- Lead Sponsor
- kasr alaini
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
a.Age between 1 - 7 years old.
b.American Society of Anesthesiologist (ASA) physical status class I- II.
c.Patients scheduled for infra-umbilical orthopedic surgeries.
Exclusion Criteria
a.Patients with known allergy to the study drugs.
b.Suspected coagulopathy.
c.Infection at the site of caudal block
d. History of developmental delay or neuromuscular disorders.
e. Skeletal deformities.
f. Patients on magnesium therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method •To evaluate the effect of dexmetedomidine in comparison to magnesium sulphate on duration of bupivacaine caudal block.
- Secondary Outcome Measures
Name Time Method To evaluate the difference between dexmetedomidine and magnesium as an adjuvant in caudal block in hemodynamics(MBP,HR) and post operative pain intensity(FLACC score).